Kodiak Sciences, Inc. (KOD)
23.81
-0.32
(-1.33%)
USD |
NASDAQ |
Dec 12, 16:00
23.82
+0.01
(+0.04%)
After-Hours: 20:00
Kodiak Sciences Shareholders Equity (Quarterly): 23.69M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cytokinetics, Inc. | -521.12M |
| ADMA Biologics, Inc. | 431.19M |
| Arcutis Biotherapeutics, Inc. | 158.07M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 218.07M |
| Total Liabilities (Quarterly) | 194.38M |
| Debt to Equity Ratio | 6.846 |
| Current Ratio | 1.785 |
| Net Debt Paydown Yield | 0.31% |